DRTS
Alpha Tau Medical Ltd- Healthcare
- Biotechnology
- $1.22B market cap
Forecast run · Oct 29, 2026Upside rank 847 of 3,186
Model Signal
ForecastQ Daily Probabilities
37.5%
41.0%
21.9%
Analyst Consensus
Recommendation2.17/5 Buy
Last price$13.16
Price target$18.00
Implied move+36.8%
Analysts6
ForecastQ Portfolios
DRTS is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.